Trial intelligence / Profile preview

Preventive use of ascorbic acid for postoperative atrial fibrillation

IRCT2016090228945N2Phase 2Completed

Sponsor
Islamic Azad University
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ascorbic acid in Atrial fibrillation (AFib), sponsored by Islamic Azad University. Started Dec 2016; status: completed.

02

Drugs

ascorbic acid
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on IRCT2016090228945N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016090228945N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call